Sophie A Jamal1. 1. Women's College Hospital, University of Toronto, Toronto, Ontario, Canada. sophie.jamal@utoronto.ca
Abstract
PURPOSE OF REVIEW: Fractures are common in patients with chronic kidney disease (CKD) and are associated with substantial morbidity and mortality. Bone mass measurements are commonly used to assess fracture risk in the general population, but the utility of these measurements in patients with CKD is unclear. RECENT FINDINGS: This review will outline the epidemiology and etiology of fractures in patients with CKD. Also, we will summarize the published data that describe the association between bone mass measurements and fracture in patients with CKD. SUMMARY: Patients with CKD suffer from fractures due to impairments in bone quantity, bone quality, and abnormalities of neuromuscular function. The complex etiology of fractures combined with the technical limitations of bone mineral density testing, both by dual energy X-ray absorptiometry and by peripheral quantitative computed tomography, limits the clinical utility of bone mass measurements for fracture prediction in CKD; this is particularly true among patients with stages 4 and 5 CKD. As such, clinicians should not routinely order bone mineral density testing in patients with CKD. Further research, to determine whether bone mineral density together with other noninvasive measures to assess bone strength can predict fracture, is needed.
PURPOSE OF REVIEW: Fractures are common in patients with chronic kidney disease (CKD) and are associated with substantial morbidity and mortality. Bone mass measurements are commonly used to assess fracture risk in the general population, but the utility of these measurements in patients with CKD is unclear. RECENT FINDINGS: This review will outline the epidemiology and etiology of fractures in patients with CKD. Also, we will summarize the published data that describe the association between bone mass measurements and fracture in patients with CKD. SUMMARY:Patients with CKD suffer from fractures due to impairments in bone quantity, bone quality, and abnormalities of neuromuscular function. The complex etiology of fractures combined with the technical limitations of bone mineral density testing, both by dual energy X-ray absorptiometry and by peripheral quantitative computed tomography, limits the clinical utility of bone mass measurements for fracture prediction in CKD; this is particularly true among patients with stages 4 and 5 CKD. As such, clinicians should not routinely order bone mineral density testing in patients with CKD. Further research, to determine whether bone mineral density together with other noninvasive measures to assess bone strength can predict fracture, is needed.
Authors: Valeria E Gómez-Islas; Kevin R García-Fong; Rosa E Aguilar-Fuentes; Salvador Hernández-Castellanos; Alfredo Pherez-Farah; Sofía A Méndez-Bribiesca; Juan M López-Navarro; Hillary K Osorio-Landa; Sergio L Carbajal-Morelos; Areli M Zúñiga-Guzmán; Iván Pérez-Díaz Journal: Bone Rep Date: 2020-07-18
Authors: Erica L Clinkenbeard; Megan L Noonan; Joseph C Thomas; Pu Ni; Julia M Hum; Mohammad Aref; Elizabeth A Swallow; Sharon M Moe; Matthew R Allen; Kenneth E White Journal: JCI Insight Date: 2019-02-21
Authors: Melissa F P Santos; Mariel J Hernández; Ivone B de Oliveira; Flávia R Siqueira; Wagner V Dominguez; Luciene M Dos Reis; Aluizio B Carvalho; Rosa M A Moysés; Vanda Jorgetti Journal: J Bone Miner Metab Date: 2018-01-25 Impact factor: 2.626
Authors: K Bleicher; R G Cumming; V Naganathan; M J Seibel; F M Blyth; D G Le Couteur; D J Handelsman; H M Creasey; L M Waite Journal: Osteoporos Int Date: 2012-12-05 Impact factor: 4.507